Franklin Covey Co is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are positive indicators such as hedge fund buying and improved financials, the stock lacks strong technical or proprietary trading signals, and options data suggests bearish sentiment. Given the user's impatience and unwillingness to wait for optimal entry points, holding off on this investment is recommended for now.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram of 0.489, indicating upward momentum. However, RSI at 78.405 is in the neutral zone, and the stock is trading near resistance levels (R1: 24.098). The pre-market and regular market changes are negative (-1.51% and -0.77%, respectively), suggesting short-term weakness.

Hedge funds are significantly increasing their buying activity (up 180.11% last quarter). Financial performance has improved YoY, with net income up 84.20% and EPS up 112.50%. Analysts have raised the price target to $25, expecting accelerated growth in the second half of 2026.
No recent news or congress trading data to support a strong buy case. Options data reflects bearish sentiment, and the stock has an 80% chance to decline by -1.28% in the next day. Gross margin has slightly decreased (-0.44% YoY).
In Q2 2026, revenue increased marginally by 0.06% YoY to $59.65M. Net income improved significantly by 84.20% YoY to -$1.98M, and EPS rose by 112.50% YoY to -0.17. However, gross margin dropped slightly to 72.87% (-0.44% YoY).
Barrington raised the price target to $25 from $22, maintaining an Outperform rating. The firm anticipates accelerated growth and profitability starting in the second half of 2026.